Insights into pancreatic islet cell dysfunction from type 2 diabetes mellitus genetics

Area of Science:

• Endocrinology and Genetics
• Molecular Biology and Disease Pathogenesis

Background:

• Type 2 diabetes mellitus (T2DM) is a growing global health concern with complex genetic and environmental origins.
• Genome-wide association studies (GWAS) have identified numerous genetic loci associated with T2DM risk.
• The pancreatic islet is increasingly recognized for its crucial role in T2DM development, supported by physiological and epigenomic data.

Purpose of the Study:

• To review the transition from T2DM genetic associations to underlying molecular mechanisms.
• To highlight methods for identifying causal variants and effector transcripts at T2DM GWAS loci.
• To discuss the utility of human models for studying pancreatic beta-cell function in T2DM.

Main Methods:

• Review of GWAS findings and their functional interrogation.
• Analysis of human models, including EndoC-β cell lines and iPSC-derived β-like cells.
• Case studies of specific T2DM susceptibility loci (e.g., CDKAL1, MTNR1B, SLC30A8, PAM).

Main Results:

• Over 400 genetic signals linked to T2DM risk have been identified through GWAS.
• Challenges remain in pinpointing causal variants and understanding their functional impact.
• Human cell models offer valuable platforms for dissecting T2DM pathogenesis at susceptible loci.

Conclusions:

• A multidisciplinary approach integrating genetics, physiology, and developmental biology is essential for elucidating T2DM mechanisms.
• Further research using advanced human models is critical for translating genetic discoveries into therapeutic strategies.
• Understanding the role of pancreatic islets in T2DM pathogenesis is key to developing effective interventions.